ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 12 analysts with an average price target of $36.42. This is a potential upside of $20.35 (126.63%) from yesterday's end of day stock price of $16.07.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 188 price targets and 179 ratings on display. The stock rating distribution of ARWR is 86.27% BUY and 13.73% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.83% with an average time for these price targets to be met of 256.95 days.

Highest price target for ARWR is $80, Lowest price target is $26, average price target is $44.5.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 20-May-2025. First documented stock forecast 18-Dec-2013.

Currently out of the existing stock ratings of ARWR, 44 are a BUY (86.27%), 7 are a HOLD (13.73%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$63.93 (397.82%)

$80

11 days ago
(20-May-2025)

0/22 (0%)

$63.71 (391.10%)

Buy

$60

$43.93 (273.37%)

$60

18 days ago
(13-May-2025)

4/20 (20%)

$44.72 (292.67%)

193

Buy

$38

$21.93 (136.47%)

$55

3 months 17 days ago
(14-Feb-2025)

8/16 (50%)

$18.89 (98.85%)

135

Buy

$42

$25.93 (161.36%)

$42

3 months 20 days ago
(11-Feb-2025)

2/10 (20%)

$23.11 (122.34%)

100

Buy

$45

$28.93 (180.02%)

$62

6 months 4 days ago
(27-Nov-2024)

22/36 (61.11%)

$18.85 (72.08%)

154

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 256.95 days on average for the stock forecasts to be realized with a an average price target met ratio 66.83

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 10 price targets and 6 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $75.13

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Alethia Young with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?